HealthMore in Health→
Non-invasive liver scans show potential to replace some biopsies in MASLD
Key Takeaways
- A Nature Medicine research briefing summarizes results from the LITMUS imaging study in MASLD.
- Elastography and elastography-based composite scores showed enough accuracy to evaluate advanced fibrosis and cirrhosis.
- The study found that current markers were not accurate enough to diagnose MASH without biopsy.
- The findings support a more targeted role for liver biopsy rather than full replacement across all MASLD assessments.
DE
DT Editorial Team··via nature.com